Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 5
1946 17
1947 20
1948 20
1949 22
1950 38
1951 34
1952 32
1953 38
1954 29
1955 36
1956 43
1957 49
1958 58
1959 50
1960 51
1961 63
1962 122
1963 238
1964 362
1965 283
1966 401
1967 478
1968 537
1969 592
1970 607
1971 759
1972 714
1973 656
1974 641
1975 502
1976 432
1977 434
1978 321
1979 357
1980 346
1981 319
1982 327
1983 326
1984 374
1985 363
1986 390
1987 349
1988 374
1989 468
1990 540
1991 672
1992 755
1993 929
1994 1106
1995 1134
1996 953
1997 1059
1998 1273
1999 1317
2000 1354
2001 1443
2002 1439
2003 1571
2004 1513
2005 1523
2006 1312
2007 1218
2008 1122
2009 1126
2010 1077
2011 1099
2012 1099
2013 1010
2014 873
2015 863
2016 745
2017 697
2018 664
2019 589
2020 606
2021 515
2022 742
2023 514
2024 276

Text availability

Article attribute

Article type

Publication date

Search Results

44,904 results

Results by year

Filters applied: . Clear all
Page 1
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial.
Lu S, Wu L, Jian H, Cheng Y, Wang Q, Fang J, Wang Z, Hu Y, Han L, Sun M, Miao L, Ding C, Cui J, Wang K, Li B, Li X, Ye F, Liu A, Pan Y, Cang S, Zhou H, Sun X, Shen Y, Wang S, Zhang W, He Y. Lu S, et al. Lancet Respir Med. 2023 Jul;11(7):624-636. doi: 10.1016/S2213-2600(23)00135-2. Epub 2023 May 5. Lancet Respir Med. 2023. PMID: 37156249 Clinical Trial.
Tirofiban-induced thrombocytopenia.
Wang J, Zou D. Wang J, et al. Ann Med. 2023 Dec;55(1):2233425. doi: 10.1080/07853890.2023.2233425. Ann Med. 2023. PMID: 37439782 Free PMC article. Review.
Covalent targeted radioligands potentiate radionuclide therapy.
Cui XY, Li Z, Kong Z, Liu Y, Meng H, Wen Z, Wang C, Chen J, Xu M, Li Y, Gao J, Zhu W, Hao Z, Huo L, Liu S, Yang Z, Liu Z. Cui XY, et al. Nature. 2024 Jun;630(8015):206-213. doi: 10.1038/s41586-024-07461-6. Epub 2024 May 22. Nature. 2024. PMID: 38778111
Repotrectinib: First Approval.
Dhillon S. Dhillon S. Drugs. 2024 Feb;84(2):239-246. doi: 10.1007/s40265-023-01990-6. Drugs. 2024. PMID: 38279972 Review.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Song Y, Malpica L, Cai Q, Zhao W, Zhou K, Wu J, Zhang H, Mehta-Shah N, Ding K, Liu Y, Li Z, Zhang L, Zheng M, Jin J, Yang H, Shuang Y, Yoon DH, Gao S, Li W, Zhai Z, Zou L, Xi Y, Koh Y, Li F, Prince M, Zhou H, Lin L, Liu H, Allen P, Roncolato F, Yang Z, Kim WS, Zhu J. Song Y, et al. Lancet Oncol. 2024 Jan;25(1):117-125. doi: 10.1016/S1470-2045(23)00589-2. Epub 2023 Dec 9. Lancet Oncol. 2024. PMID: 38092009 Clinical Trial.
44,904 results
You have reached the last available page of results. Please see the User Guide for more information.